Gilead
ApprovedGilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer & inflammation.
Founded
1987
Focus
Small Molecules
About
Gilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer & inflammation.
Funding History
1Total raised: $86.3M
IPO$86.3MUndisclosedJan 22, 1992
FDA Approved Drugs
29YEZTUGONDAJun 18, 2025
YEZTUGONDAJun 18, 2025
LIVDELZINDAAug 14, 2024
Company Info
TypePrivate
Founded1987
LocationFoster City, United States
StageApproved
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile